Document is current
Any future updates will be listed below
-
Authors
Ko, Randy F.
Davidson, Oliver Q. C.
Ahmed, Michael A.
Clark, Ross M.
Brandenburg, Jacquelyn S.
Pankratz, Vernon S.
Sharma, Geetanjali
Hathaway, Helen J.
Prossnitz, Eric R.
Howdieshell, Thomas R.
-
Funding
Funding for this research was provided by:
National Institutes of Health (CA163890, F31DK136330, UL1TR001449, CA118100, CA163890)
- License Information
-
More Information
Article History
Received: 1 February 2024
Accepted: 25 July 2024
First Online: 8 August 2024
Competing interests
: ERP holds a patent on small molecules regulators of GPER activity. All other authors declare that they have no competing interests.
